Status:
COMPLETED
Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status
Lead Sponsor:
Public Health England
Collaborating Sponsors:
Royal Free and University College Medical School
Conditions:
Influenza
Eligibility:
All Genders
50-80 years
Phase:
PHASE4
Brief Summary
The study is being undertaken to evaluate responses to seasonal influenza vaccine in older adults with respect to their CMV status. CMV is cytomegalovirus and is an organism that infects many people, ...
Detailed Description
Human cytomegalovirus (HCMV) is an important pathogen or disease-causing virus, which can result in disease in the unborn child as well as in individuals whose immune systems are not working properly ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- No contraindications to vaccination as specified in the "Green Book" - Immunisation Against Infectious Disease, HMSO.
- Written informed consent obtained
- Subject aged no less than 50 years 0 days and no older than 79 years and 364 days at enrollment.
Exclusion
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00442975
Start Date
March 1 2007
End Date
September 1 2007
Last Update
August 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hertfordshire Primary Care Trust
Stevenage, United Kingdom